Adaptive Cancer Treatment Solutions for Unique Operational Environments

Publication ID: 24-11857522_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Cancer Treatment Solutions for Unique Operational Environments,” Published Technical Disclosure No. 24-11857522_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857522_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,522.

Summary of the Inventive Concept

This inventive concept adapts tucaresol-based compositions for specific, niche markets and extreme operational environments, enhancing cancer treatment accessibility and efficacy.

Background and Problem Solved

The original patent disclosed tucaresol-based compositions for cancer treatment, but it did not address the unique challenges posed by high-altitude regions, disaster relief scenarios, extreme weather conditions, high-security facilities, or remote areas. This inventive concept solves these problems by integrating tucaresol-based compositions with specialized devices, systems, and methods tailored to these specific environments.

Detailed Description of the Inventive Concept

The inventive concept comprises five specialized variations: (1) a system for treating cancer in high-altitude regions, featuring a composition containing tucaresol or its analogs and a device for monitoring oxygen levels; (2) a method for disaster relief, involving administration of a pharmaceutical composition containing tucaresol or its analogs and provision of a portable shelter; (3) a kit for extreme weather conditions, consisting of a pharmaceutical composition containing tucaresol or its analogs and a water-resistant container; (4) a system for treating cancer in high-security facilities, featuring a composition containing tucaresol or its analogs and a biometric authentication device; and (5) a method for treating cancer in remote areas, utilizing a drone delivery system and remote patient response monitoring.

Novelty and Inventive Step

The new claims introduce novel combinations of tucaresol-based compositions with specialized devices, systems, and methods tailored to unique operational environments, which are not obvious from the original patent. The inventive step lies in the adaptation of the original composition to address the specific challenges and limitations of these environments.

Alternative Embodiments and Variations

Alternative embodiments may include integrating tucaresol-based compositions with other specialized devices, such as wearable oxygen sensors, portable power generators, or satellite communication systems. Variations may involve adapting the composition for use in other extreme environments, such as space exploration or deep-sea operations.

Potential Commercial Applications and Market

This inventive concept has significant commercial potential in the pharmaceutical and biotechnology industries, particularly in the areas of cancer treatment, disaster relief, and remote healthcare. The target market includes healthcare providers, governments, and organizations operating in unique operational environments.

CPC Classifications

SectionClassGroup
A A61 A61K31/192
A A61 A61K31/496
A A61 A61K39/3955
A A61 A61P35/00
C C07 C07K16/2818
C C07 C07K16/2827
A A61 A61K2039/505

Original Patent Information

Patent NumberUS 11,857,522
TitleCompositions containing tucaresol or its analogs
Assignee(s)BeyondSpring Pharmaceuticals, Inc.